Retatrutide

Retatrutide Product Description
Retatrutide is a synthetic, long-acting research peptide engineered as a triple receptor agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This multi-target mechanism makes it highly relevant in laboratory studies focused on metabolic regulation, appetite control, and energy balance.

Designed with enhanced stability for extended activity, Retatrutide is widely studied for its potential role in weight management, glucose metabolism, and fat oxidation. Its unique triple-action profile distinguishes it from traditional single or dual agonist peptides, making it a promising subject in advanced metabolic and endocrinology research.

Peptide Information

Property	Value
Peptide Type	Triple Agonist (GLP-1, GIP, Glucagon)
Molecular Formula	C221H342N46O68
Molecular Weight	~4737 g/mol
CAS Number	Not publicly standardized
Synonyms	LY3437943, Triple Hormone Receptor Agonist, GLP-1/GIP/Glucagon Agonist

Lyophilized Peptides:
This peptide is supplied in lyophilized (freeze-dried) form to maintain structural integrity, stability, and purity during storage and handling. This process helps extend shelf life without the use of fillers or additives.

---

Product Usage:
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information provided is for educational and research purposes. This product must be handled only by licensed, qualified professionals. It is not intended for human consumption, medical, veterinary, or cosmetic use.